Related references
Note: Only part of the references are listed.Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19
Kiran Bharat Lokhande et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Bidirectional Molecule Generation with Recurrent Neural Networks
Francesca Grisoni et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Linlin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Assessing the impact of generative AI on medicinal chemistry
W. Patrick Walters et al.
NATURE BIOTECHNOLOGY (2020)
De novo generation of hit-like molecules from gene expression signatures using artificial intelligence
Oscar Mendez-Lucio et al.
NATURE COMMUNICATIONS (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Deja vu: Stimulating open drug discovery for SARS-CoV-2
Sean Ekins et al.
DRUG DISCOVERY TODAY (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
Andre Fischer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT
Xinhao Li et al.
JOURNAL OF CHEMINFORMATICS (2020)
SMILES-based deep generative scaffold decorator for de-novo drug design
Josep Arus-Pous et al.
JOURNAL OF CHEMINFORMATICS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Yang Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses
Sirin Theerawatanasirikul et al.
ANTIVIRAL RESEARCH (2020)
The SARS-CoV-2 main protease as drug target
Sven Ullrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M. Ghahremanpour et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul et al.
PLOS MEDICINE (2020)
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Mohamed Mahdi et al.
VIROLOGY JOURNAL (2020)
Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
Martiniano Bello et al.
JOURNAL OF MOLECULAR MODELING (2020)
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations
Son Tung Ngo et al.
RSC ADVANCES (2020)
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
Mario Roberto Senger et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)
Generative molecular design in low data regimes
Michael Moret et al.
NATURE MACHINE INTELLIGENCE (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
GuacaMol: Benchmarking Models for de Novo Molecular Design
Nathan Brown et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Coronavirus envelope protein: current knowledge
Dewald Schoeman et al.
VIROLOGY JOURNAL (2019)
Analyzing Learned Molecular Representations for Property Prediction
Kevin Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings
Rafael Ferreira Dantas et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Daniel Merk et al.
MOLECULAR INFORMATICS (2018)
FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery
David Lagorce et al.
BIOINFORMATICS (2017)
Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research
Martin Pouliot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
Jonathan B. Baell
JOURNAL OF NATURAL PRODUCTS (2016)
Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras
Lili Kuo et al.
JOURNAL OF VIROLOGY (2016)
The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets
Takaya Saito et al.
PLOS ONE (2015)
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
Mark Turlington et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure-activity relationship study
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction
Robert P. Sheridan
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions
Peter Ertl et al.
JOURNAL OF CHEMINFORMATICS (2009)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)
ALARM NMR: A rapid and robust experimental method to detect reactive false positives in biochemical screens
JR Huth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro
RP Jain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Share Paper
